Robert R Graham Selected Research

Virus Diseases (Viral Diseases)

12/2010

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert R Graham Research Topics

Disease

17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2015 - 09/2002
8	Autoimmune Diseases (Autoimmune Disease) 12/2015 - 09/2002
6	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 08/2012
5	Rheumatoid Arthritis 06/2019 - 09/2002
3	Inflammation (Inflammations) 10/2022 - 05/2011
2	IgA Deficiency 01/2012 - 04/2007
2	Disease Susceptibility (Diathesis) 08/2007 - 09/2002
1	Muscular Atrophy (Muscle Atrophy) 01/2024
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2024
1	Glycogen Storage Disease (Glycogenosis) 01/2024
1	Asthma (Bronchial Asthma) 10/2022
1	Cognitive Dysfunction 01/2022
1	Schizophrenia (Dementia Praecox) 01/2020
1	Glaucoma 01/2020
1	Infections 11/2018
1	Geographic Atrophy 01/2017
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Hypersensitivity (Allergy) 11/2016
1	Lupus Nephritis 12/2014
1	Crohn Disease (Crohn's Disease) 02/2014
1	Starvation 02/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Primary Immunodeficiency Diseases 01/2012
1	Neoplasms (Cancer) 05/2011
1	Necrosis 03/2011
1	Oral Ulcer (Mouth Ulcer) 02/2011
1	Arthritis (Polyarthritis) 02/2011
1	Virus Diseases (Viral Diseases) 12/2010
1	HIV Infections (HIV Infection) 12/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2010
1	Nephritis 01/2008
1	Type 1 Maturity-Onset Diabetes of the Young 03/2005
1	Type 2 Diabetes Mellitus (MODY) 03/2005

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2010
5	HLA Antigens (Human Leukocyte Antigens)IBA 11/2012 - 09/2002
3	InterferonsIBA 01/2014 - 03/2011
3	Interferon Type IIBA 10/2012 - 05/2006
3	AutoantibodiesIBA 03/2011 - 08/2007
2	CytokinesIBA 10/2022 - 03/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2012
2	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 12/2014 - 08/2007
2	Immunoglobulin A (IgA)IBA 01/2012 - 09/2010
2	AntibodiesIBA 10/2011 - 01/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2011 - 09/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 04/2007
1	GlycogenIBA 01/2024
1	AcidsIBA 01/2024
1	Glycogen Synthase (Synthase I)IBA 01/2024
1	EnzymesIBA 01/2024
1	GlucosidasesIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Kallikreins (Kallikrein)IBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	PeriostinIBA 10/2022
1	Neutralizing AntibodiesIBA 10/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2019
1	Glycoproteins (Glycoprotein)IBA 11/2018
1	LigandsIBA 11/2018
1	Immunoglobulins (Immunoglobulin)IBA 11/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	lampalizumabIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	chemotactic factor inactivatorIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Complement Factor I (C3b Inactivator)IBA 01/2017
1	Complement Factor D (Factor D)IBA 01/2017
1	Deoxyribonucleases (DNase)FDA Link 11/2016
1	Surface Antigens (Surface Antigen)IBA 12/2015
1	Alanine (L-Alanine)FDA Link 02/2015
1	Threonine (L-Threonine)FDA Link 02/2015
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 12/2014
1	Netrin ReceptorsIBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2014
1	Caspase 3 (Caspase-3)IBA 02/2014
1	CaspasesIBA 02/2014
1	Death Domain ReceptorsIBA 02/2014
1	ChemokinesIBA 01/2014
1	macrophage stimulating proteinIBA 01/2013
1	anti-dsDNA autoantibodyIBA 03/2011
1	Amino Acids FDA Link 12/2010
1	Peptides (Polypeptides)IBA 12/2010
1	Antinuclear AntibodiesIBA 05/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 11/2009
1	ProlactinIBA 05/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2009
1	P-2 (P 2)IBA 09/2007
1	Histocompatibility Antigens Class IIIBA 08/2007
1	Factor V (Coagulation Factor V)IBA 04/2007
1	Interferon Regulatory FactorsIBA 05/2006
1	Hepatocyte Nuclear FactorsIBA 03/2005
1	EpitopesIBA 09/2002

Therapy/Procedure

1	Enzyme Replacement Therapy 01/2024
1	Therapeutics 01/2024
1	Oral Administration 01/2024
1	Intravitreal Injections 01/2017